Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("FRENKEL, Eugene P")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 29

  • Page / 2
Export

Selection :

  • and

Clinical and laboratory features and sequelae of deficiency of folic acid (folate) and vitamin B12 (cobalamin) in pregnancy and gynecologyFRENKEL, Eugene P; YARDLEY, Denise A.Hematology/oncology clinics of North America. 2000, Vol 14, Num 5, issn 0889-8588, viii,1079-1100 [23 p.]Article

Cobalamin profiles in patients after urinary diversionSAGALOWSKY, Arthur I; FRENKEL, Eugene P.The Journal of urology. 2002, Vol 167, Num 4, pp 1696-1700, issn 0022-5347Article

Hyperhomocysteinemia and thrombosisLEE, Ray; FRENKEL, Eugene P.Hematology/oncology clinics of North America. 2003, Vol 17, Num 1, issn 0889-8588, vi, 85-102 [19 p.]Article

The paradoxical effect of bevacizumab in the therapy of malignant gliomasTHOMPSON, Eric M; FRENKEL, Eugene P; NEUWELT, Edward A et al.Neurology. 2011, Vol 76, Num 1, pp 87-93, issn 0028-3878, 7 p.Article

Sticky platelet syndrome and thrombocythemiaFRENKEL, Eugene P; MAMMEN, Eberhard F.Hematology/oncology clinics of North America. 2003, Vol 17, Num 1, issn 0889-8588, vi, 63-83 [22 p.]Article

Acquired platelet dysfunctionSHEN, Yu-Min P; FRENKEL, Eugene P.Hematology/oncology clinics of North America. 2007, Vol 21, Num 4, issn 0889-8588, vi, 647-661 [16 p.]Article

Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapySARODE, Ravindra; RAWAL, Ajay; LEE, Ray et al.British journal of haematology. 2006, Vol 132, Num 5, pp 604-607, issn 0007-1048, 4 p.Article

Synergy between methionine stress and chemotherapy in the treatment of brain tumor xenografts in athymic miceKOKKINAKIS, Demetrius M; HOFFMAN, Robert M; FRENKEL, Eugene P et al.Cancer research (Baltimore). 2001, Vol 61, Num 10, pp 4017-4023, issn 0008-5472Article

Enhanced transgene expression in androgen independent prostate cancer gene therapy by taxane chemotherapeutic agentsYINGMING LI; OKEGAWA, Takatsugu; LOMBARDI, Donald P et al.The Journal of urology. 2002, Vol 167, Num 1, pp 339-346, issn 0022-5347Article

Heparin-induced thrombocytopenia, paradoxical thromboembolism, and other adverse effects of heparin-type therapyWALENGA, Jeanine M; FRENKEL, Eugene P; BICK, Rodger L et al.Hematology/oncology clinics of North America. 2003, Vol 17, Num 1, pp viii-ix, issn 0889-8588, 26 p.Article

Enhanced chemosensitivity to irinotecan by RNA interference-mediated down-regulation of the nuclear factor-κB p65 subunitJUN GUO; VERMA, Udit N; GAYNOR, Richard B et al.Clinical cancer research. 2004, Vol 10, Num 10, pp 3333-3341, issn 1078-0432, 9 p.Article

Increased toxicity and lack of efficacy of rofecoxib in combination with chemotherapy for treatment of metastatic colorectal cancer: A phase II studyBECERRA, Carlos R; FRENKEL, Eugene P; ASHFAQ, Raheela et al.International journal of cancer. 2003, Vol 105, Num 6, pp 868-872, issn 0020-7136, 5 p.Article

Comparison of a rapid platelet function assay -Verify Now™ Aspirin - : with whole blood impedance aggregometry for the detection of aspirin resistanceDYSZKIEWICZ -KORPANTY, Anna M; KIM, Anne; BURNER, James D et al.Thrombosis research. 2007, Vol 120, Num 4, pp 485-488, issn 0049-3848, 4 p.Article

The direct thrombin inhibitors: Their role and use for rational anticoagulationFRENKEL, Eugene P; SHEN, Yu-Min; HALEY, Barbara B et al.Hematology/oncology clinics of North America. 2005, Vol 19, Num 1, pp vi-vii, issn 0889-8588, 29 p.Article

Unfractionated heparin, low molecular weight heparins, and pentasaccharide: Basic mechanism of actions, pharmacology, and clinical useBICK, Rodger L; FRENKEL, Eugene P; WALENGA, Jeanine et al.Hematology/oncology clinics of North America. 2005, Vol 19, Num 1, issn 0889-8588, v, 1-51 [52 p.]Article

Circulating half-life of PEGylated recombinant methioninase holoenzyme is highly dose dependent on cofactor pyridoxal-5'-phosphateZHIJIAN YANG; XINGHUA SUN; YOSHIOKA, Takayuki et al.Cancer research (Baltimore). 2004, Vol 64, Num 16, pp 5775-5778, issn 0008-5472, 4 p.Article

Using iron oxide nanoparticles to diagnose CNS inflammatory diseases and PCNSLFARRELL, Brian T; HAMILTON, Bronwyn E; NEUWELT, Edward A et al.Neurology. 2013, Vol 81, Num 3, pp 256-263, issn 0028-3878, 8 p.Article

Upregulation of TRAG3 gene in urothelial carcinoma of the bladderKARAM, Jose A; HUANG, Sandra; XIAOYUAN CHEN et al.International journal of cancer (Print). 2011, Vol 128, Num 12, pp 2823-2832, issn 0020-7136, 10 p.Article

PEGylation confers greatly extended half-life and attenuated immunogenicity to recombinant methioninase in primatesZHIJIAN YANG; JUNHUA WANG; DONGDONG ZHANG et al.Cancer research (Baltimore). 2004, Vol 64, Num 18, pp 6673-6678, issn 0008-5472, 6 p.Article

Pharmacokinetics, methionine depletion, and antigenicity of recombinant methioninase in primatesZHIJIAN YANG; JUNHUA WANG; HOFFMAN, Robert M et al.Clinical cancer research. 2004, Vol 10, Num 6, pp 2131-2138, issn 1078-0432, 8 p.Article

Inactivation of Cyclin D2 gene in prostate cancers by aberrant promoter methylationPADAR, Asha; SATHYANARAYANA, Ubaradka G; SUZUKI, Makoto et al.Clinical cancer research. 2003, Vol 9, Num 13, pp 4730-4734, issn 1078-0432, 5 p.Article

Molecular detection of noninvasive and invasive bladder tumor tissues and exfoliated cells by aberrant promoter methylation of laminin-5 encoding genesSATHYANARAYANA, Ubaradka G; MARUYAMA, Riichiroh; GAZDAR, Adi F et al.Cancer research (Baltimore). 2004, Vol 64, Num 4, pp 1425-1430, issn 0008-5472, 6 p.Article

Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced squamous cell carcinoma of the head and neckROSENTHAL, David I; LEE, Jason H; MILLER, Linda K et al.Journal of clinical oncology. 2001, Vol 19, Num 5, pp 1363-1373, issn 0732-183XArticle

Assessment of HER-2/neu status in breast cancer: Automated Cellular Imaging System (ACIS)-assisted quantitation of immunohistochemical assay achieves high accuracy in comparison with fluorescence in situ hybridization assay as the standardWANG, Sijian; SABOORIAN, M. Hossein; FRENKEL, Eugene P et al.American journal of clinical pathology. 2001, Vol 116, Num 4, pp 495-503, issn 0002-9173Article

Circulating tumor cells in patients with breast cancer dormancySONGDONG MENG; TRIPATHY, Debasish; HALEY, Barbara et al.Clinical cancer research. 2004, Vol 10, Num 24, pp 8152-8162, issn 1078-0432, 11 p.Article

  • Page / 2